Aquabounty Technologies Inc (OQ:AQB)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for AQB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Frank David A Direct Ownership Common Stock P - Open market or private purchase 35,000 $1.50
Feb 18/20 Feb 13/20 Kirk Randal J Indirect Ownership Common Stock P - Open market or private purchase 5,175,000 $1.50
Jan 6/20 Nov 1/19 Olsen Angela M Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 35,000  
Nov 7/19 Nov 1/19 Olsen Angela M Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 35,000  
Nov 7/19 Nov 1/19 Olsen Angela M Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 30,043  
May 1/19 May 1/19 Perez Jeffrey Thomas Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 6/19 Apr 30/19 Wulf Sylvia Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 150,000  
May 6/19 Apr 30/19 Stotish Ronald L Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 50,000  
May 6/19 Apr 30/19 Rojas Alejandro Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 30,000  
May 6/19 Apr 30/19 Frank David A Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for AQB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 18/20 Feb 13/20 Kirk Randal J Indirect Ownership Common Stock P - Open market or private purchase 5,175,000 $1.50
Feb 14/20 Feb 13/20 Frank David A Direct Ownership Common Stock P - Open market or private purchase 35,000 $1.50
Jan 6/20 Nov 1/19 Olsen Angela M Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 35,000  
Nov 7/19 Nov 1/19 Olsen Angela M Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 35,000  
Nov 7/19 Nov 1/19 Olsen Angela M Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 30,043  
May 6/19 Apr 30/19 Wulf Sylvia Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 150,000  
May 6/19 Apr 30/19 Stotish Ronald L Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 50,000  
May 6/19 Apr 30/19 Rojas Alejandro Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 30,000  
May 6/19 Apr 30/19 Frank David A Direct Ownership Options to Purchase Common Stock A - Grant, award or other under Rule 16b-3(d) 20,000  
May 1/19 May 1/19 Perez Jeffrey Thomas Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $AQB

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)